Looking at the universe of stocks we cover at Dividend Channel, in trading on Thursday, shares of Merck & Co Inc (Symbol: MRK) were yielding above the 3% mark based on its quarterly dividend ...

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $15.6 billion and adjusted earnings of $1.72 per share, ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK options ...

Merck stock gapped up on news regarding its c19 drug, molnupiravir - namely the drug's phase 3 trial interim results. The market seems to be prematurely pricing in the approval of the drug as well as ...